Frekhtman & Associates

Facebook

Twitter

Copyright 2003 by Frekhtman & Associates.
All Rights Reserved.
COVID-19 NOTICE: We are open and fully operational.
Our law firm is following CDC safety regulations, We are available by phone, email, text/chat, or video.

NO FEE
PROMISE

(866) 288-9529

24/7 Free & Confidential Consultations

Search
Menu
 

Mass Torts

Can Surgical Staplers Cause Serious Injuries & Death?

Surgical Staplers Cause Serious Injuries

During the past two years, the Food and Drug Administration (FDA) has issued news releases, recalls, guidelines and other materials regarding surgical and implantable staples. This has been in response to the very large number of medical device reports (MDRs) that were submitted to the FDA between January 1, 2011 and March 31, 2018. In fact, at least 41,000 MDRs were received by the FDA during that time period (some experts claim that number is far higher). Numerous issues have been raised about the dangers posed to patients by both surgical and implantable staples. Unfortunately, too many patients are still suffering...

Continue reading

Invokana Amputation Lawyer Discusses Clinical Trials and FDA Warnings

On May 16, 2017, the U.S. Food and Drug Administration (FDA) posted a safety alert regarding amputation risks associated with the diabetes medication Canagliflozin (Invokana, Invokamet XR and Invokamet). An Invokana Amputation Lawyer at the F&A Injury Law Firm in New York, NY explains that this FDA alert included a “black box warning,” which the FDA says is “designed to call attention to serious or life-threatening risks.” What is Invokana (Canagliflozin)? Invokana is a single-ingredient prescription medication that, along with exercise and a special diet, lowers blood sugar in adults diagnosed with Type II diabetes. Invokana is in a group of prescription drugs commonly referred to...

Continue reading

Taxotere Hair Loss: Breast Cancer Drug Causes Alopecia in Women

It was back during the late 1990s that the U. S. Food and Drug Administration (FDA) first approved injections of docetaxel (brand name Taxotere®) for different forms of cancer. Since that time, it’s been approved to treat breast, prostate, head, and neck cancers. Patients suffering from gastric cancers and non-small cell lung cancer have also been advised to use this drug. At present, many patients are now filing lawsuits claiming their doctors failed to inform them that using this drug could result in permanent (not just temporary) hair loss. While some observers have tried to minimize the significance of permanent hair...

Continue reading